Reaction

Animal Bite reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,603 reports · 62 co-occurring drugs

As of the last recalculation, Animal Bite appears in 2,603 FAERS reports alongside 62 co-occurring drug terms. The strongest observed disproportionality signal is HUMAN IMMUNOGLOBULIN G (PRR 15.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Human Immunoglobulin G	39	15.3	15.4
Diphenhydramine Hydrochloride Capsule, Liquid Filled	36	13.6	13.7
Adrenalinum	66	13.0	13.0
Infliximab-Dyyb	41	11.4	11.4
Amoxicillin And Clavulanate Potassium	34	10.1	10.1
Calcium, Magnesium, Potassium, And Sodium Oxybates	10	9.3	9.3
Epinephrine	74	9.3	9.3
Thyroid, Porcine	11	8.3	8.3
Liothyronine Sodium	8	7.4	7.4
Lidicaine	44	7.3	7.3
Burn Relief	44	7.3	7.3
Lidocaine Hydrochloride And Epinephrine	44	7.3	7.3
Lidocaine, Menthol	44	7.2	7.2
Emicizumab	11	7.1	7.2
Lidocaine	50	7.0	7.0
Diphenhydramine	53	6.8	6.8
Azelastine	15	6.7	6.7
Lidocaine Hydrochloride And Epinephrine Bitartrate	44	6.7	6.7
Lidocaine 4%	44	6.6	6.6
Mupirocin	10	5.9	6.0
Mupirocin Calcium	10	5.8	5.8
Doxyclycline Hyclate	12	5.7	5.7
Dicyclomine Hydrochloride	10	5.6	5.6
Voclosporin	6	5.5	5.5
Omalizumab	52	5.0	5.0
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate	21	4.8	4.8
Adalimumab	374	4.8	4.8
Niraparib	13	4.7	4.7
Tocilizumab	60	4.3	4.3
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate	22	4.3	4.3
Mometasone Furoate And Formoterol Fumarate Dihydrate	8	4.1	4.1
Etanercept	281	4.1	4.1
Buprenorphine Hydrochloride, Naloxone Hydrochloride	12	4.0	4.0
Upadacitinib	40	4.0	4.0
Bimekizumab	10	3.8	3.8
Secukinumab	72	3.6	3.6
Interferon Beta-1A	80	3.4	3.4
Vedolizumab	35	3.3	3.3
Risankizumab-Rzaa	33	3.3	3.3
Ocrelizumab	25	3.2	3.2
Riociguat	13	3.2	3.2
Ibrutinib	32	3.2	3.2
Ofatumumab	13	3.1	3.1
Eculizumab	21	3.1	3.1
Sodium Oxybate	24	2.9	2.9
Pegvaliase-Pqpz	3	2.9	2.9
Amphetamine	3	2.9	2.9
Diclofenac Potassium, Film Coated	3	2.9	2.9
Diclofenac Potassium Tablets	3	2.9	2.9
Belimumab	11	2.8	2.8
Tofacitinib	63	2.8	2.8
Natalizumab	61	2.7	2.7
Siponimod	3	2.7	2.7
Avapritinib	4	2.6	2.6
Vilazodone Hydrochloride	3	2.6	2.6
Naltrexone	10	2.6	2.6
Ixekizumab	9	1.9	1.9
Rimegepant Sulfate	3	1.9	1.9
Romosozumab-Aqqg	3	1.8	1.8
Guselkumab	6	1.3	1.3
Erenumab-Aooe	8	1.2	1.2
Dupilumab	61	1.0	1.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.